Press Releases

Date Title and Summary
Toggle Summary Capnia Appoints William G. Harris to its Board of Directors
REDWOOD CITY, Calif., June 30, 2014 / PRNewswire / -- Capnia, Inc., a privately held maker of diagnostic devices to detect analytes in exhaled breath, today announced the appointment of William G. Harris to its Board of Directors. Mr. Harris brings to Capnia more than 20 years of financial
Toggle Summary Capnia Appoints Gina Phelps as Vice President of Sales
REDWOOD CITY, Calif., July 7, 2014 / PRNewswire / -- Capnia, Inc., a privately held maker of diagnostic devices that detect analytes in exhaled breath, today announced the appointment of Gina Phelps as Vice President of Sales, a newly created position. Ms.
Toggle Summary Capnia Appoints David O'Toole as Chief Financial Officer
REDWOOD CITY, Calif., July 9, 2014 / PRNewswire / -- Capnia, Inc., a privately held maker of diagnostic devices that detect analytes in exhaled breath, today announced the appointment of David O'Toole as Chief Financial Officer, a significant expansion of the executive management.
Toggle Summary Capnia, Inc. Announces Pricing of Initial Public Offering
REDWOOD CITY, Calif. , Nov. 13, 2014 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN) announced today the pricing of its initial public offering of 1,650,000 units, each unit consisting of one share of common stock, one Series A warrant to purchase one share of common stock and one Series B warrant to
Toggle Summary Capnia, Inc. Announces Closing of Initial Public Offering and Partial Exercise of Over-Allotment Option
REDWOOD CITY, Calif. , Nov. 18, 2014 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN) announced today the closing of its initial public offering of 1,650,000 units, each unit consisting of one share of common stock, one Series A warrant to purchase one share of common stock and one Series B warrant to
Toggle Summary Capnia Presents CoSense® Data at the 2014 American Society of Hematology Annual Meeting
REDWOOD CITY, Calif. , Dec. 8, 2014 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN), focused on the development of medical diagnostics based on its proprietary Sensalyze™ technology for precision metering of gas flow, today announced a poster presentation at the 2014 American Society of Hematology
Toggle Summary Capnia Reports Third Quarter 2014 Financial Results
REDWOOD CITY, Calif. , Dec. 18, 2014 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN), focused on the development of medical diagnostics based on its proprietary Sensalyze™ Technology Platform for precision metering of gas flow, today announced financial results for the third quarter and nine months
Toggle Summary Capnia to Present at OneMedForum 2015
REDWOOD CITY, Calif. , Jan. 5, 2015 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN), focused on the development of novel diagnostics and therapeutics based on its proprietary technologies for precision metering of gas flow, today announced that Anish Bhatnagar , M.D., Chief Executive Officer, will
Toggle Summary Capnia and Clinvest® Partner to Develop Cluster Headache Therapeutic
REDWOOD CITY, Calif. , Jan. 6, 2015 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN), focused on the development of novel diagnostics and therapeutics based on its proprietary technologies for precision metering of gas flow, and Clinvest®, a research organization dedicated to the advancement of
Toggle Summary Capnia Applies for Orphan Drug Designation in the U.S. for the Treatment of Trigeminal Neuralgia
REDWOOD CITY, Calif. , Jan. 8, 2015 / PRNewswire / -- Capnia, Inc. (NASDAQ: CAPN), focused on the development of novel diagnostics and therapeutics based on its proprietary technologies for precision metering of gas flow, today announced that it has submitted an application to the U.S.
Print Page RSS Feeds Email Alerts IR Contacts